HANLY ANN M. 4
4 · Vir Biotechnology, Inc. · Filed Mar 31, 2021
Insider Transaction Report
Form 4
HANLY ANN M.
EVP & Chief Technology Officer
Transactions
- Award
Common Stock
2021-03-29+30,000→ 30,000 total - Award
Employee Stock Option (Right to Buy)
2021-03-29+60,000→ 60,000 totalExercise: $48.38Exp: 2031-03-28→ Common Stock (60,000 underlying)
Footnotes (1)
- [F1]1/4 of the shares subject to the stock option vest and become exercisable on March 29, 2022, and the remainder vest in 36 equal monthly installments thereafter.